Rhino-orbital zygomycosis secondary to rhizopus oryzae in a renal transplant recipient successfully treated with liposomal amphotericin B

Chang Gung Medical Journal

Volumn 31, Issue 4, 2008, Pages 407-411

  Yassin, Mohammed Abdel Daem ^a,b   Taj Aldeen, S J ^a   Khan, F Y ^a   Errayes, M ^a   Aref, E ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b Al Amal Hospital   (Qatar)

Author keywords

Liposomal amphotericin B; Renal transplant; Rhizopus oryzae; Zygomycosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; ENDOSCOPIC SURGERY; FUNGUS CULTURE; GRAFT RECIPIENT; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; KIDNEY FUNCTION; KIDNEY GRAFT; LABORATORY TEST; MALE; MUCORMYCOSIS; NOSE SMEAR; ORBIT CELLULITIS; RHIZOPUS ORYZAE; TREATMENT OUTCOME;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; HUMANS; KIDNEY TRANSPLANTATION; MALE; NOSE DISEASES; ORBITAL DISEASES; RHIZOPUS; RISK FACTORS; ZYGOMYCOSIS;

EID: 48749133694     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41:634-53.
2. Wang JL, Hsiao CH, Chang SC, Hsueh PR, Chen YC. Diagnostic challenge of zygomycosis in compromised hosts. Med Mycol 2006;44:19-24.
3. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994;39:3-22.
4. Akoz T, Civelek B, Akan M. Rhinocerebral mucormycosis: report of two cases. Ann Plast Surg 1999;43:309-12.
5. Schell WA. Histopathology of fungal rhinosinusitis. Otolaryngol Clin North Am 2000;33:251-76.
6. Ferguson BJ. Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am 2000;3:349-65.
7. Goldblum SE, Reed WP. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980;93:597-613.
8. Chinn RY, Diamond RD. Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun 1982;38:1123-9.
9. Jorens PG, Boelaert JR, Halloy V, Zamora R, Schneider YJ, Herman AG. Human and rat macrophages mediate fungistatic activity against Rhizopus species differently: in vitro and ex vivo studies. Infect Immun 1995;63:4489-94.
10. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993;16:677-88.
11. Strasser MD, Kennedy RJ, Adam RD. Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex. Arch Intern Med 1996;156:337-9.
12. Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE; Eurofung Network. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003;51:45-52.
13. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004;350:951-2.
14. Brugiere O, Dauriat G, Mal H, Marrash-Chalha R, Fournier M, Groussard O, Besnard M, Leseche G, Dupont B. Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy. Transplantation 2005;80:1361-2.
15. Hilal AA, Taj-Aldeen SJ, Mirghani AH. Rhinoorbital mucormycosis secondary to Rhizopus oryzae: a case report and literature review. Ear Nose Throat J 2004;83:556, 558-60, 562.